Singapore Stock Market: STI Technical Analysis 16 March

Market Review for STI: Singapore share prices opened lower with the Straits Times Index (STI) down 0.75 points to 3,362.02, tracing losses in the US markets. Singapore stocks hung on to their gains at noon after opening lower because Singapore-listed companies received an increase of 7.1 per cent in the median of the average director's fee - or S$60,000 per annum - in the financial year 2013/2014, compared to S$56,000 in the previous financial year.
STI Day Performance
Open: 3361.38
High: 3387.36
Low: 3358.03
Close: 3376.04
Change(Points): +13.27
% Change: 0.40%
Volume: 1050.5M
Rise: 143
Fall: 260
Unch; 381
Market forecast for STI: After one week STI was positive now we are expecting STI will be positive in next trading session.
STRAITS TIME  LEVELS
Support 1: 3340
Support 2: 3320
Support 3: 3300
Resistance 1: 3400
Resistance 2: 3420
Resistance 3: 3440
Technical Indicators: RSI is at 43 and CCI is at -134.
Top Gainers: sia.sg, thaibev.sg, jardine c&c.sg, jsh usd.sg, golden agri-res.sg
Top Losers: noble.sg, hongkongland usd.sg, sembcorp marine.sg, starhub.sg, sgx.sg
Important Factor for today:-

• The Monetary Authority of Singapore (MAS) said, last tuesday, it was reviewing and might delay the scheduled 1 June 2015 rollout of tighter macro-prudential measures to limit consumer debt.
• China's fiscal income rose just 3.2 per cent between January and February compared with the same period a year ago,well below an 8.6 per cent gain seen in the same period of 2014.
• Oil touched its lowest level since 2009, dragging Asian energy shares down amid increased projections for US production. The dollar weakened from its strongest in more than a decade to major peers ahead of this week's Federal Reserve meeting.
• Media group Singapore Press Holdings (SPH) has notified the Singapore Exchange of its move to buy a 20 per cent stake in a local start-up that offers quick and convenient access to curated data about companies and the people who run or own them.
• Singapore's anti-trust regulator blocked a takeover for the first time when it provisionally ruled last week that Malaysian IHH Healthcare Bhd's planned purchase of a local unit of India's Fortis Healthcare would lessen competition.